Skip to content
Home/Companies/Biotech/Kamau Therapeutics
KT

Kamau Therapeutics

Biotech·United States·Active·2yr hold

Kamau Therapeutics is a biotech company, headquartered in United States.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Kamau Therapeutics?

Kamau Therapeutics is currently owned by Neva SGR through Neva II (2024 vintage), since 2024.

Hand-verified · updated 2026-07-23

Neva SGR
Investor
Neva SGR
Neva II · 2024 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Neva II

Other portfolio companies in the same fund.

Straiker
Active
CybersecurityUnited States· 2026
Commonwealth Fusion Systems
Active
EnergyUnited States· 2025
deskbird
Active
HR TechSwitzerland· 2025
Nuclidium
Active
BiotechSwitzerland· 2025
Phosphorus
Exited 2026
CybersecurityUnited States· 2025
to
Ternary
Active
SaaSUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings